Novel methods for earlier detection of coronary artery calcium using CT
Novel methods for earlier detection of coronary artery calcium using CT
批准号:
9910824
负责人:
Lauren Severance
金额:
$3.84万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2023-03-31
关键词:
Agatston ScoreAgeCalciumCause of DeathCessation of lifeCoronary ArteriosclerosisCoronary VesselsCoronary arteryCoronary heart diseaseDependenceDetectionDevelopmentDiseaseEarly DiagnosisElectrocardiogramEventExposure toGeneticGenetic RiskGenotypeGuidelinesHeart DiseasesHourImageImage AnalysisIndividualLesionLow-Density LipoproteinsMeasurementMeasuresMethodsMorphologic artifactsMotionNaturePreventiveProbabilityProtocols documentationResearch ProposalsRiskRisk FactorsScanningScoring MethodSpiral Computed TomographySubgroupSymptomsTechniquesTechnologyUpdateVariantVisualWorkX-Ray Computed Tomographyagedbasecalcificationchest computed tomographyclinical biomarkerscohortcoronary artery calcificationcoronary artery calciumcoronary calcium scoringcostdensitygenetic variantgenome wide association studyheart disease riskheart motionhigh riskimage reconstructionimprovedinnovationlifetime riskmortalitynovelreconstructionscreeningsextool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Coronary heart disease (CHD) is the most common form of heart disease, the leading cause of death worldwide.
Traditional risk prediction tools such as the Framingham Risk Score use clinical biomarkers to identify individuals
who are of higher risk for an adverse CHD event and would therefore benefit from preventive LDL-C lowering
therapy. However, these tools identify very few younger individuals who are at increased risk, despite the fact
that longer cumulative exposure to lower LDL-C shows increased protection from CHD events. Coronary artery
calcium (CAC) measured via CT is the best novel predictor of CHD events and is predictive of CHD events
among young individuals. Recent guideline updates recommend LDL-C lowering therapy in individuals with any
detectable CAC. Coronary calcification progresses with age, so scanning all younger individuals will result in a
very low positive rate of detection. Age independent risk factors, such as genetic risk, are needed to determine
which younger individuals will benefit the most from early calcium screening. Additionally, current CAC scoring
methods are based on outdated technology, and there is a critical need to understand scan sensitivity to non-
zero CAC detection. CAC detection is a function of both plaque size and calcium density, and the influence of
motion introduces an additional technical challenge. The focus of this work is to develop novel image scanning
and reconstruction methods for earlier CAC detection using CT and to apply innovative risk prediction tools to
develop a successful CAC screening strategy. This work will identify the appropriate age for each individual to
begin CAC screening with CT using the age independent risk factors of sex and genetics. Additionally, the
minimum detectable mass of CAC by CT will be assessed and improved by optimizing scan acquisition and
reconstruction methods. Finally, new image analysis techniques for discovery of non-zero CAC in standard
helical chest CT scans with motion artifact will be derived. The proposed project will establish novel scan
acquisition, image reconstruction, and risk prediction tools for CAC detection that will improve CAC measurement
as a screening strategy for CHD. These developments will permit earlier detection of CAC in young individuals
who have previously been misclassified as disease free.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel methods for earlier detection of coronary artery calcium using CT
-
批准号:10460282
-
项目类别:
-
资助金额:$1.27万
-
财政年份:2020
-
负责人:Lauren Severance
-
依托单位:
Novel methods for earlier detection of coronary artery calcium using CT
-
批准号:10383126
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2020
-
负责人:Lauren Severance
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: